Results 141 to 150 of about 2,771,911 (398)
Correction: Auxin Influx Carriers Control Vascular Patterning and Xylem Differentiation in Arabidopsis thaliana. [PDF]
PLoS Genetics, 2015 PLOS Genetics Staff
doaj +1 more source
FEBS Letters, EarlyView.The S1025 peptide is the major antidote to the YrzI toxin, which we renamed here as SpyT (Small Peptide YrzI Toxin) and SpyA (Small Peptide YrzI Antitoxin) (1). Degradation of the toxin–antitoxin spyTA mRNA, either by a translation‐dependent cleavage by the endoribonuclease Rae1 (2) or by direct attack by 3′‐exoribonucleases (3), also contributes to ...
Laetitia Gilet +4 more
wiley +1 more source
Genetics of osteoporosis [PDF]
Current Opinion in Endocrinology and Diabetes, 1995 There is clear evidence of genetic modulation of bone phenotype parameters including bone density, quantitative ultrasound, bone size, and bone turnover. At any particular age and phase of life, genetic factors explain about 70% of the variance in bone phenotype after adjustment for major medical and disease factors.
openaire +5 more sources
Expression of Concern: RNAi-Dependent and Independent Control of LINE1 Accumulation and Mobility in Mouse Embryonic Stem Cells. [PDF]
PLoS Genetics, 2015 PLOS Genetics Editors
doaj +1 more source
GENETICS OF NATURAL POPULATIONS IX. TEMPORAL CHANGES IN THE COMPOSITION OF POPULATIONS OF DROSOPHILA PSEUDOOBSCURA [PDF]
, 1943 Th. Dobzhansky
openalex +1 more source
FEBS Letters, EarlyView.α2 → 8 polysialic acid elicits poor immunogenicity. Small‐angle scattering shows a supramolecular structure with parallel‐chain binding, although in different forms at μm and mm calcium. The major histocompatibility complex requires molecular weights around 2000 Da to produce antibodies, and 2000 Da polysialic oligomers will bind in these structures ...
Kenneth A. Rubinson
wiley +1 more source
FEBS Letters, EarlyView.Venom peptides have shown promise in treating pain. Our study uses computer screening to identify a peptide that targets a sodium channel (NaV1.7) linked to chronic pain. We produced the peptide in the laboratory and refined its design, advancing the search for innovative pain therapies.
Gagan Sharma +8 more
wiley +1 more source